Diphtheria and Tetanus Antibody Persistence in Indian Pre-school Children and Response to a Booster Dose of DT Vaccine.

DOI: 10.4236/wjv.2011.11002   PDF   HTML     4,589 Downloads   10,296 Views   Citations


Despite effective vaccines, diphtheria (D) resurged recently in the former socialistic block, and tetanus (T) still occurs in less privileged countries. We studied the antibody persistence for D and T in Indian pre-school children who had received four doses of DTP vaccine and subsequently, the response to a booster dose. Anti-D and anti-T IgG antibodies prior to and one month after a DT vaccine were measured by ELISA in 223 healthy children of 4-6 years who had previously received four doses of the triple vaccine. Adverse reactions were monitored for one month. While 30% and 14% of subjects were susceptible to D and T, respectively, 98% and 100% of them attained seroprotection post-vaccination. Both responses were significant. Local, but not systemic reactions except fever were rather common. A high proportion of the Indian pre-school population is susceptible to D and T, despite of receiving four doses. The current policy of giving the fifth dose at this age is appropriate.

Share and Cite:

A. Satwekar, S. Telang, N. Ghorpade, P. Barde, M. Patwardhan and P. Kulkarni, "Diphtheria and Tetanus Antibody Persistence in Indian Pre-school Children and Response to a Booster Dose of DT Vaccine.," World Journal of Vaccines, Vol. 1 No. 1, 2011, pp. 5-9. doi: 10.4236/wjv.2011.11002.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Hardy IR, Dittmann S, Sutter RW. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet, Vol. 347, No. 9017, June 1996, pp. 1739-44.
[2] Dittmann S. Epidemic diphtheria in the Newly Independent States of the former USSR--situation and lessons learned. Biologicals, Vol. 25, No. 2, Jun 1997, pp. 179-86.
[3] Galazka AM, Robertson SE. Diphtheria. In: Murray CJL, Lopez AD, Mathers CD, Editors. The Global Epidemiology of Infectious Disease. Cambridge, MA: Harvard University Press: 2004.
[4] Galazka A, Birmingham M, Kurian M, Gasse FL. Tetanus. In: Murray CJL, Lopez AD, Mathers CD, Editors. The Global Epidemiology of Infectious Disease. Cambridge, MA: Harvard University Press:2004.
[5] Nandi R, De M, Browning S, Purkayastha P, Bhattacharjee AK. Diphtheria: the patch remains. J Laryngol Otol, Vol. 117, No. 10, Oct 2003, pp. 807-10.
[6] Lodha R, Dash NR, Kapil A, Kabra SK. Diphtheria in urban slums in north India. Lancet, Vol. 355, No. 9199, Jan 2000, pp. 204.
[7] WHO vaccine-preventable diseases: monitoring system 2009 global summary. Immunization, Vaccines and Biologicals. World Health Organization. Internet available: http://whqlibdoc.who.int/hq/2009/WHO_IVB_ 2009_eng.pdf.
[8] India 2008. EPI Fact sheet. World Health Organization. Internet available: http://www.searo.who.int/vaccine/LinkFiles/EPI2008/India08.pdf.
[9] Anuradha S. Tetanus in adults—a continuing problem: an analysis of 217 patients over 3 years from Delhi, India, with special emphasis on predictors of mortality. Med J Malaysia, Vol. 61, No. 1, Mar 2006, pp. 7-14.
[10] Diphtheria vaccine. WHO position paper. Wkly Epidemiol Rec, Vol.81, No. 3, 2006, pp. 24-32. Core Programme Clusters. Family and Community Health. Routine Immunization. Internet available: http://www.whoindia.org/EN/Section6/Section284/Section286_508.htm.
[11] Ohuabunwo C, Perevoscikovs J, Griskevica A, Gargiullo P, Brilla A, Viksna L et al. Respiratory diphtheria among highly vaccinated military trainees in Latvia: improved protection from DT compared with Td booster vaccination. Scand J Infect Dis, Vol. 37, No.11-12, 2005, pp. 813-20.
[12] Shimoni Z, Dobrousin A, Cohen J, Pitlik S. Tetanus in an immunised patient. BMJ, Vol. 319, No. 7216, Oct 1999, pp. 1049.
[13] Vinson DR. Immunisation does not rule out tetanus. BMJ, Vol. 320, No. 7231, Feb 2000, pp. 383.
[14] Tharmaphornpilas P, Yoocharoan P, Prempree P, Youngpairoj S, Sriprasert P, Vitek CR. Diphtheria in Thailand in the 1990s. J Infect Dis, Vol. 184, No. 8, Oct 2001, pp. 1035-40.
[15] Divino-Goes KG, Moraes-Pinto MI, Dinelli MI, Casagrande ST, Bonetti TC,Andrade PR, Weckx LY. Prevalence of diphtheria and tetanus antibodies and circulation of Corynebacterium diphtheriae in S?o Paulo, Brazil. Braz J Med Biol Res, Vol. 40, No. 12, Dec 2007, pp. 1681-7.
[16] Ciofi degli Atti ML, Salmaso S, Cotter B, Gallo G, Alfarone G, Pinto A, Bella A, von Hunolstein C. Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age. Vaccine, Vol. 20, No. 1-2, Oct 2001, pp. 74-9.
[17] Blennow M, Granstr?m M, Strandell A. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine, Vol. 12, No. 5, Apr 1994, pp. 427-30.
[18] Mark A, Carlsson RM, Granstr?m M. Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. Vaccine, Vol. 17, No. 15-16, Apr 1999, pp. 2067-72.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.